title: Treatment with adjuvant endocrine therapy for early-stage breast cancer: is it forever?
authors.affiliation: Dana-Farber Cancer Institute, Boston, MA bovermoyer@partners.org.
authors.forename: Beth
authors.initials: B
authors.lastname: Overmoyer
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009570:Nitriles / Q000008:administration & dosage*; D013629:Tamoxifen / Q000008:administration & dosage*; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen